Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Structural biology

Ribosome revelations

Nature volume 513, pages 491–492 (2014)Cite this article

Subjects

Proteins are synthesized in cells by the ribosome apparatus. A report of 16 yeast ribosome structures, each bound by a different inhibitor, broadens our understanding of how drugs affect ribosome activity. See Article p.517

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Binding sites of protein-translation inhibitors in the yeast ribosome.

References

  1. Garreau de Loubresse, N. et al. Nature 513, 517–522 (2014).

    Article  CAS  ADS  Google Scholar 

  2. Wilson, D. N. Crit. Rev. Biochem. Mol. Biol. 44, 393–433 (2009).

    Article  CAS  Google Scholar 

  3. Wimberley, B. T. Curr. Opin. Invest. Drugs 10, 750–765 (2009).

    Google Scholar 

  4. Perez-Fernandez, D. et al. Nature Commun. 5, 3112; http://dx.doi.org/10.1038/ncomms4112 (2014).

    Article  ADS  Google Scholar 

  5. Taguchi, A. et al. ChemMedChem http://dx.doi.org/10.1002/cmdc.201402208 (2014).

  6. Schneider-Poetsch, T. et al. Nature Chem. Biol. 6, 209–217 (2010).

    Article  CAS  Google Scholar 

  7. Schuwirth, B. S. et al. Science 310, 827–834 (2005).

    Article  CAS  ADS  Google Scholar 

  8. Wong, W. et al. eLife 3, e03080 (2014).

    Article  Google Scholar 

  9. Bai, X., Fernandez, I. S., McMullan, G. & Scheres, S. H. eLife 2, e00461 (2013).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nelson B. Olivier is in the Innovative Medicines and Early Development Unit, AstraZeneca Pharmaceuticals, Cambridge Science Park, Cambridge CB4 0FZ, UK.,

    Nelson B. Olivier

Authors
  1. Nelson B. Olivier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nelson B. Olivier.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Olivier, N. Ribosome revelations. Nature 513, 491–492 (2014). https://doi.org/10.1038/nature13747

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature13747

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing